Peter Kufer
彼得·库弗
Ph.D.
Vice President, BiTE TechnologyBiTE技术副总裁
👥Biography 个人简介
Peter Kufer is the co-inventor of BiTE technology who has led its development for over 22 years from first demonstration in 1994 through multiple FDA approvals. As VP of BiTE Technology at Amgen Research Munich, he directs ongoing platform optimization and next-generation BiTE development. He received the 2023 George B. Rathmann Award for Scientific Excellence, becoming only the fourth recipient. With 137 publications and 9,932 citations, Kufer represents the continuity of BiTE innovation from Micromet through the Amgen era, ensuring the platform continues evolving to address emerging clinical needs.
Peter Kufer博士是BiTE技术的共同发明者,22年来一直领导其从1994年首次展示到多个FDA批准的开发。作为安进慕尼黑研究中心BiTE技术副总裁,他指导平台优化和下一代BiTE开发。他获得2023年George B. Rathmann科学卓越奖,成为第四位获奖者。凭借137篇出版物和9,932次引用,Kufer代表了BiTE创新从Micromet到安进时代的连续性,确保平台继续发展以应对新兴临床需求。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
BiTE Technology Co-invention
Co-invented BiTE platform with first demonstration of T-cell redirection via bispecific antibodies in 1994
Platform Leadership
22+ years of continuous BiTE platform development from Micromet founding through Amgen acquisition and beyond
Representative Works 代表性著作
T cell-engaging BiTE antibodies - Mechanism of action and implications for development
Immunological Reviews (2016)
Comprehensive platform review from technology inventor perspective
CD33/CD3 bispecific antibody (AMG 330) demonstrates prolonged pharmacokinetics
Clinical Cancer Research (2019)
Next-generation BiTE optimization for AML
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-03-11 | All information from publicly available academic sources
Related Experts 相关专家
关注 彼得·库弗 的研究动态
Follow Peter Kufer's research updates
留下邮箱,当我们发布与 Peter Kufer(Amgen Research Munich)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment